ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease – Science Daily

Continue reading

2017-12-12 Michael Zand NEWS

Editas Medicine Out with News, Shares Drop – Baystreet.ca

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Science Daily
“Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need,” said Dr. Leslie Kean, the trial’s principal investigator and associate director of the Ben Towne …

and more »

Continue reading

2017-12-12 Michael Zand NEWS

Editas Medicine Out with News, Shares Drop – Baystreet.ca


Nasdaq

Editas Medicine Out with News, Shares Drop
Baystreet.ca
Editas’ Chief Scientific Officer Charles Albright declared, “We are encouraged by these results demonstrating efficient targeted integration at the beta-hemoglobin locus with CRISPR/Cas9 and results demonstrating efficient on target editing of adult …
Head to Head Comparison: Organovo (ONVO) versus Editas …TrueBlueTribune
Zacks’ 7 Best Strong Buys for 2018Zacks.com

all 21 news articles »

Continue reading

2017-12-12 Michael Zand NEWS

Editas Medicine Out with News, Shares Drop – Baystreet.ca


TrueBlueTribune

Editas Medicine Out with News, Shares Drop
Baystreet.ca
Editas’ Chief Scientific Officer Charles Albright declared, “We are encouraged by these results demonstrating efficient targeted integration at the beta-hemoglobin locus with CRISPR/Cas9 and results demonstrating efficient on target editing of adult …
Head to Head Comparison: Organovo (ONVO) versus Editas …TrueBlueTribune
Zacks’ 7 Best Strong Buys for 2018Zacks.com
SEC FORM 4 – SEC.govSEC.gov

all 29 news articles »

Continue reading

2017-12-12 Michael Zand NEWS

If CRISPR is so amazing, why can’t we edit human genes yet? – ABC Online

Editas Medicine Out with News, Shares Drop
Baystreet.ca
Editas’ Chief Scientific Officer Charles Albright declared, “We are encouraged by these results demonstrating efficient targeted integration at the beta-hemoglobin locus with CRISPR/Cas9 and results demonstrating efficient on target editing of adult …

Continue reading

2017-12-12 Michael Zand NEWS

In Phase 2 Trial, Orencia Prevented Graft-Versus-Host Disease After Stem Cell Transplant – Immuno-Oncology News

Immuno-Oncology NewsIn Phase 2 Trial, Orencia Prevented Graft-Versus-Host Disease After Stem Cell TransplantImmuno-Oncology News“Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients rema… Continue reading

2017-12-12 Michael Zand NEWS

2017 Was the Year of Immunotherapy for Bladder Cancer – Curetoday.com

Curetoday.com2017 Was the Year of Immunotherapy for Bladder CancerCuretoday.comThere were monumental advances in the treatment of bladder cancer during the year 2017, with five approvals for checkpoint inhibitors in both the first and second line setti… Continue reading

2017-12-12 Michael Zand NEWS

CRISPR Therapeutics and Vertex team up to advance and commercialize lead gene editing candidate for blood … – Seeking Alpha

FierceBiotechCRISPR Therapeutics and Vertex team up to advance and commercialize lead gene editing candidate for blood …Seeking AlphaCRISPR Therapeutics (CRSP -4.9%) and Vertex Pharmaceuticals (VRTX -0.5%) have agreed to co-develop and co-commerciali… Continue reading

2017-12-12 Michael Zand NEWS
  • 1
  • …
  • 791
  • 792
  • 793
  • 794
  • 795
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

ABC Online

If CRISPR is so amazing, why can’t we edit human genes yet?
ABC Online
The quick, easy and cheap gene editing tool was hailed as the “breakthrough of 2015” by Science magazine. It has the potential to change entire family lineages, treating disorders from cancer to HIV. Yet five years after bursting onto the scene, CRISPR …
Genetic Differences Could Impact Efficacy and Safety of CRISPRGenetic Engineering & Biotechnology News
Searching for the CRISPR swiss-army knifeEurekAlert (press release)
A CRISPR system to turn genes on : Research Highlights – NatureNature.com
GenomeWeb –Diabetes.co.uk –Seeking Alpha
all 25 news articles »